Albaño, Crispina I.

HRN: 08-71-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/23/2025
11/30/2025
IV
4.5g
Q6H
Septic Shock
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines